| PHPIX | RMQAX | PHPIX / RMQAX | |
| Total Expense Ratio | 1.78 | 1.26 | 141% |
| Annual Report Gross Expense Ratio | 2.53 | 1.82 | 139% |
| Fund Existence | 26 years | 12 years | - |
| Gain YTD | 29.104 | 17.708 | 164% |
| Front Load | N/A | 5% | - |
| Min. Initial Investment | 15000 | 2500 | 600% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 8.58M | 749M | 1% |
| Annual Yield % from dividends | 0.69 | 0.00 | 22,903% |
| Returns for 1 year | 100.52 | -0.76 | -13,312% |
| Returns for 3 years | 71.89 | 43.33 | 166% |
| Returns for 5 years | 49.73 | 28.81 | 173% |
| Returns for 10 years | 75.56 | 888.75 | 9% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| AWSSX | 18.66 | 0.11 | +0.59% |
| Invesco Global Core Equity R6 | |||
| CISIX | 62.68 | 0.34 | +0.55% |
| Calvert US Large Cap Core Rspnb Idx I | |||
| IVRSX | 32.73 | -0.22 | -0.67% |
| VY® Columbia Real Estate S | |||
| DIHRX | 16.65 | -0.15 | -0.89% |
| DFA Intl Hi Relatv Profitability Instl | |||
| SBHIX | 27.85 | -0.32 | -1.14% |
| Saratoga Health & Biotechnology I | |||